Charles Schwab Investment Management Inc. Purchases 76,469 Shares of Haleon PLC Sponsored ADR $HLN

Key Points

• Charles Schwab Investment Management Inc. increased its shares in Haleon PLC Sponsored ADR by 28.8%, owning 342,213 shares valued at approximately $3.5 million as of the latest SEC filing.
• Haleon announced a semi-annual dividend increase to $0.0555, which will be paid on September 18th, representing a dividend yield of 190.0%.
• Wall Street analysts have a positive outlook on Haleon, with most ratings indicating a Moderate Buy and a consensus target price of $12.33.

Charles Schwab Investment Management Inc. increased its stake in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 28.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 342,213 shares of the company's stock after acquiring an additional 76,469 shares during the quarter. Charles Schwab Investment Management Inc.'s holdings in Haleon were worth $3,521,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of HLN. Point72 Asset Management L.P. bought a new position in Haleon during the 4th quarter worth approximately $45,110,000. Northern Trust Corp grew its position in Haleon by 27.7% during the 4th quarter. Northern Trust Corp now owns 5,412,542 shares of the company's stock worth $51,636,000 after acquiring an additional 1,172,931 shares during the last quarter. Royal Bank of Canada grew its position in Haleon by 62.6% during the 4th quarter. Royal Bank of Canada now owns 2,733,615 shares of the company's stock worth $26,078,000 after acquiring an additional 1,052,462 shares during the last quarter. Voloridge Investment Management LLC bought a new position in Haleon during the 4th quarter worth approximately $5,499,000. Finally, Cubist Systematic Strategies LLC bought a new position in Haleon during the 4th quarter worth approximately $4,022,000. 6.67% of the stock is currently owned by institutional investors.

Haleon Price Performance

Shares of NYSE:HLN traded down $0.02 during trading on Thursday, hitting $9.88. 921,263 shares of the company's stock were exchanged, compared to its average volume of 12,620,468. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.87 and a quick ratio of 0.63. Haleon PLC Sponsored ADR has a 52-week low of $8.86 and a 52-week high of $11.42. The business's 50-day simple moving average is $9.81 and its 200 day simple moving average is $10.21. The company has a market cap of $44.27 billion, a price-to-earnings ratio of 25.42, a PEG ratio of 2.89 and a beta of 0.24.

Haleon Increases Dividend

The firm also recently announced a semi-annual dividend, which will be paid on Thursday, September 18th. Investors of record on Friday, August 15th will be given a dividend of $0.0555 per share. This is an increase from Haleon's previous semi-annual dividend of $0.05. This represents a dividend yield of 190.0%. The ex-dividend date is Friday, August 15th. Haleon's dividend payout ratio (DPR) is 28.21%.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Morgan Stanley upgraded Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price objective on the stock in a research report on Friday, May 9th. BNP Paribas Exane upgraded Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price objective on the stock in a research report on Tuesday, May 27th. Wall Street Zen lowered Haleon from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Finally, BNP Paribas upgraded Haleon to a "strong-buy" rating in a research report on Tuesday, May 27th. Two analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and four have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Haleon currently has an average rating of "Moderate Buy" and an average target price of $12.33.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.